Tags : Drug Development

GSK and AstraZeneca Plan to Deploy NVIDIA’s Supercomputer for Drug

Shots: NVIDIA reports that it is building the “Cambridge-1” supercomputer, which will be an NVIDIA DGX SuperPOD system capable of delivering 400+ petaflops of AI performance and 8 petaflops of Linpack performance and 1s expected to come online by the end of 2020 GSK and AstraZeneca will be the first company to harness Cambridge-1 for […]Read More

Yuhan Pharmaceutical Collaborates with Cyclica to Enhance Drug Development Utilizing

Shots: Cyclica to receive up front and milestones on completion of specific objectives. Yuhan will leverage Cyclica’s AI integrated drug discovery platform, Ligand Design and Ligand Express in two separate R&D programs Yuhan enhance its drug development efforts by utilizing AI integrated drug discovery platform across multiple therapeutic areas to develop novel therapies targeting Yuhan’s […]Read More

Evotec Signs an Agreement with Sanofi for Novel Drug Development

Shots: Sanofi and Evotec launches BRIDGE LAB031, designed to convert academic research into drug discovery candidates for multiple therapeutic areas. BRIDGE is a public-private partnership combining academia, biotech and venture capital into pharma for early-stage projects The companies will focus on development of multiple small molecule programmes through lead optimization for next three years Evotec […]Read More